https://www.switzerlandweekly.com/article/907148079-from-first-time-manager-to-institutional-platform-how-cv5-capital-supports-the-full-lifecycle Switzerland Weekly en PressRelease 2026-04-21T15:01:34+00:00 From First-Time Manager to Institutional Platform: How CV5 Capital Supports the Full Lifecycle https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24837411-david-lloyd-cv5-capital-1076x1156.png https://www.switzerlandweekly.com/article/906977417-deepjudge-and-epiq-partner-to-scale-ai-across-law-firm-institutional-knowledge Switzerland Weekly en PressRelease 2026-04-21T13:00:00+00:00 DeepJudge and Epiq Partner to Scale AI Across Law Firm Institutional Knowledge https://www.switzerlandweekly.com/article/907031004-my-arcade-launches-the-atari-gamestation-gamepad-worldwide Switzerland Weekly en PressRelease 2026-04-21T13:00:00+00:00 MY ARCADE® Launches the ATARI® GAMESTATION GAMEPAD Worldwide https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24836875-gamestation-gamepad-1429x1429.jpeg https://www.switzerlandweekly.com/article/907119115-la-floride-reste-une-destination-d-investissement-strat-gique-pour-les-acheteurs-immobiliers-europ-ens-selon-mrmvr Switzerland Weekly en PressRelease 2026-04-21T11:27:39+00:00 La Floride reste une destination d'investissement stratégique pour les acheteurs immobiliers européens, selon MRMVR https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/23938158-kevin-ducros-896x1088.jpeg https://www.switzerlandweekly.com/article/907053250-cortexforge-marks-year-one-with-integration-as-the-first-proof Switzerland Weekly en PressRelease 2026-04-21T10:42:13+00:00 CortexForge Marks Year One with Integration as the First Proof https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24836930-imperyx-material-intelligence-c-574x843.png https://www.switzerlandweekly.com/article/907003308-soma-to-develop-bedrocan-eu-gmp-cannabis-extracts-for-global-medical-markets Switzerland Weekly en PressRelease 2026-04-21T08:00:00+00:00 SOMAÍ to develop Bedrocan EU-GMP Cannabis Extracts for Global Medical Markets https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24024695-soma-white-background-3375x3375.png https://www.switzerlandweekly.com/article/907084823-strategic-expansion-into-continental-europe Switzerland Weekly en PressRelease 2026-04-21T07:14:26+00:00 Strategic Expansion into Continental Europe https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/18085360-vidac-pharma-1500x767.jpeg https://www.switzerlandweekly.com/article/906283666-en-suisse-romande-36-de-la-population-a-d-j-t-victime-d-une-fraude-ou-d-une-tentative-de-fraude-sur-smartphone Switzerland Weekly en PressRelease 2026-04-21T05:50:00+00:00 En Suisse romande, 36% de la population a déjà été victime d'une fraude ou d'une tentative de fraude sur smartphone https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835065-smartphone-3840x2160.jpeg https://www.switzerlandweekly.com/article/906284609-in-der-schweiz-war-bereits-ein-drittel-der-bev-lkerung-opfer-eines-betrugs-oder-eines-betrugsversuchs-auf-dem-smartphone Switzerland Weekly en PressRelease 2026-04-21T05:50:00+00:00 In der Schweiz war bereits ein Drittel der Bevölkerung Opfer eines Betrugs oder eines Betrugsversuchs auf dem Smartphone https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835065-smartphone-3840x2160.jpeg https://www.switzerlandweekly.com/article/906975987-agrolidya-announces-strong-investor-demand-for-poultry-investment-project-in-turkey-as-phase-one-sells-out Switzerland Weekly en PressRelease 2026-04-20T17:34:54+00:00 AGROLIDYA Announces Strong Investor Demand for Poultry Investment Project in Turkey as Phase One Sells Out https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24836504-poultry-farm-jpeg-1280x720.jpeg https://www.switzerlandweekly.com/article/907074659-addex-gabab-pam-candidate-demonstrates-robust-anti-tussive-activity-in-non-human-primate-chronic-cough-model Switzerland Weekly en PressRelease 2026-04-21T05:00:00+00:00 Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model https://ml-eu.globenewswire.com/media/e6c12443-4244-46f9-909c-5ab241bbea41/small/logo-jpg.jpg https://www.switzerlandweekly.com/article/906173515-the-medical-affairs-professional-society-maps-announces-presenters-for-their-2026-emea-annual-meeting-in-zurich Switzerland Weekly en PressRelease 2026-04-20T14:00:00+00:00 The Medical Affairs Professional Society (MAPS) Announces Presenters for their 2026 EMEA Annual Meeting in Zurich https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834739-new-zurich-logo-1000x346.png https://www.switzerlandweekly.com/article/906922944-revmate-franchit-un-cap-strat-gique-et-valide-son-mod-le-avec-des-gains-mesurables-en-revenue-management-multi-h-tel Switzerland Weekly en PressRelease 2026-04-20T12:00:00+00:00 RevMate franchit un cap stratégique et valide son modèle avec des gains mesurables en revenue management multi-hôtel https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24836140-revmate-lancement-2026-2659x2659.png https://www.switzerlandweekly.com/article/906910831-updated-walmart-us-laboratory-assignment-list-expands-sgs-testing-scope Switzerland Weekly en PressRelease 2026-04-20T08:49:12+00:00 Updated Walmart US Laboratory Assignment List expands SGS testing scope https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24836097-2885-walmart-4095x2732.jpeg https://www.switzerlandweekly.com/article/906937311-newcelx-updates-corporate-presentation-to-highlight-type-1-diabetes-flagship-program-following-strategic-collaboration-with-eledon-pharmaceuticals Switzerland Weekly en PressRelease 2026-04-20T11:37:00+00:00 NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference https://ml.globenewswire.com/media/ac801d4e-6ea5-4452-87c2-aa6a05bec73c/small/logo-positive-2x-jpg.jpg https://www.switzerlandweekly.com/article/906909326-oculis-announces-completion-of-last-patient-visit-in-phase-3-diamond-program-with-ocs-01-eye-drops-for-the-treatment-of-diabetic-macular-edema Switzerland Weekly en PressRelease 2026-04-20T08:00:00+00:00 Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema https://ml-eu.globenewswire.com/media/f6fa6e90-83a4-4baa-a3b6-5483017d26b9/small/oculis-logo-gradient-jpg-resized-jpg.jpg